The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Transgenic Mice Overexpressing Human Fibroblast Growth Factor 23 (R176Q) Delineate a Putative Role for Parathyroid Hormone in Renal Phosphate Wasting Disorders
Abstract
Fibroblast growth factor 23 (FGF23) is a recently characterized protein likely involved in the regulation of serum phosphate homeostasis. Increased circulating levels of FGF23 have been reported in patients with renal phosphate-wasting disorders, but it is unclear whether FGF23 is the direct mediator responsible for the decreased phosphate transport at the proximal renal tubules and the altered vitamin D metabolism associated with these states. To examine this question, we generated transgenic mice expressing and secreting from the liver human FGF23 (R176Q), a mutant form that fails to be degraded by furin proteases. At 1 and 2 months of age, mice carrying the transgene recapitulated the biochemical (decreased urinary phosphate reabsorption, hypophosphatemia, low serum 1,25-dihydroxyvitamin D3) and skeletal (rickets and osteomalacia) alterations associated with these disorders. Unexpectantly, marked changes in parameters of calcium homeostasis were also observed, consistent with secondary hyperparathyroidism. Moreover, in the kidney the anticipated alterations in the expression of hydroxylases associated with vitamin D metabolism were not observed despite the profound hypophosphatemia and increased circulating levels of PTH, both major physiological stimuli for 1,25-dihydroxyvitamin D3 production. Our findings strongly support the novel concept that high circulating levels of FGF23 are associated with profound disturbances in the regulation of phosphate and vitamin D metabolism as well as calcium homeostasis and that elevated PTH levels likely also contribute to the renal phosphate wasting associated with these disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“suggesting that in the current study elevated iFGF23 did not inhibit PTH secretion but rather PTH stimulated iFGF23, eventually to lower plasma Pi [4, 39].”
From Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels (2025) · cites this paper as [4]
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,503
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K., Evans, W. E., O'Riordan, J., Speer, M., Econs, M., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,467
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.101545198 · Cited by 1,391
Shimada, T., Kakitani, M., Yamazaki, Y., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419081 · Cited by 1,368
Francis, F., Hennig, S., Korn, B., Reinhardt, R., de Jong, P., Poustka, A. J., Lehrach, H. R., Rowe, P. S., Goulding, J. N., Summerfield, T. C., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-130 · Cited by 1,095
Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia
Jonsson, K. B., Zahradnik, R. J., Larsson, T. E., White, K. E., Sugimoto, T., Imanishi, Y., Yamamoto, T., Hampson, G., Koshiyama, H., Ljunggren, Ö., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020881 · Cited by 904
NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATION
Walton, R. J., & Bijvoet, O. L. M. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92736-1 · Cited by 892
Yamazaki, Y., Okazaki, R., Shibata, M., Hasegawa, Y., Satoh, K., Tajima, T., Takeuchi, Y., Fujita, T., Nakahara, K., Yamashita, T., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021105 · Cited by 670
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
Riminucci, M., Collins, M. T., Fedarko, N. S., Cherman, N., Corsi, A., White, K. E., Waguespack, S. G., Gupta, A., Hannon, T. S., Econs, M. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18399 · Cited by 656
Cited by
Sorted by citations
Items 201–300 of 329
Emerging role of a phosphatonin in mineral homeostasis and its derangements
Bielesz, B. O. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01659.x · Cited by 17
Calcium Extrusion Pump PMCA4: A New Player in Renal Calcium Handling?
van Loon, E. P. M., Little, R., Prehar, S., Bindels, R. J. M., Cartwright, E. J., & Hoenderop, J. G. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153483 · Cited by 16
The adaptability of Hy-Line Brown laying hens to low-phosphorus diets supplemented with phytase
Ren, Z., Sun, W., Cheng, X., Liu, Y., Han, D., Yan, J., Pan, C., Duan, Y., & Yang, X. (2020) · Poultry Science · doi:10.1016/j.psj.2020.03.033 · Cited by 16
Ren, Y., Liu, Y., Jiang, K., Li, L., Jiao, N., Zhu, Z., Zhang, K., Jiang, S., Yang, W., & Li, Y. (2023) · Animals · doi:10.3390/ani13061042 · Cited by 19
Normal FGF23 Levels in Adult Idiopathic Phosphate Diabetes
Laroche, M., Boyer, J., Jahafar, H., Allard, J., & Tack, I. (2009) · Calcified Tissue International · doi:10.1007/s00223-008-9204-8 · Cited by 16
Fibroblast growth factor 23 and acute kidney injury
Neyra, J. A., Moe, O. W., & Hu, M. C. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-3006-1 · Cited by 17
Negri, A. L. (2013) · International Urology and Nephrology · doi:10.1007/s11255-012-0370-2 · Cited by 16
Lipocalin-2: a novel link between the injured kidney and the bone
Courbon, G., & David, V. (2022) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000804 · Cited by 16
Phosphatonins: physiological role and pathological changes.
Cavalli, L., Mazzotta, C., & Brandi, M. L. (2012) · Europe PMC (PubMed Central) · Cited by 16
Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels
Gerber, J. S., Arroyo, E. M. P., Pastor, J., Correia, M., Rudloff, S., Moe, O. W., Egli-Spichtig, D., Mohebbi, N., & Wagner, C. A. (2025) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03046-4 · Cited by 15
Tang, P., Geddes, R. F., Jepson, R. E., & Elliott, J. (2021) · The Veterinary Journal · doi:10.1016/j.tvjl.2021.105719 · Cited by 15
Osteo-Renal Cross-Talk and Phosphate Metabolism by the FGF23-Klotho System
Ohnishi, M., & Razzaque, M. S. (2013) · Contributions to nephrology · doi:10.1159/000346774 · Cited by 15
Chronic Kidney Disease-Mineral Bone Disorder
Moe, S. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00008-x · Cited by 15
Hum, J. M., Clinkenbeard, E. L., Ip, C. S., Cass, T. A., Allen, M. R., & White, K. E. (2017) · Bone Reports · doi:10.1016/j.bonr.2017.01.003 · Cited by 14
The osteocyte—A novel endocrine regulator of body phosphate homeostasis
Cheng, F., & Hulley, P. A. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.08.011 · Cited by 14
Park, J., Heo, Y.-J., Kim, D., Kim, Y.-B., Kwon, B.-Y., Song, J.-Y., & Lee, K.-W. (2024) · Poultry Science · doi:10.1016/j.psj.2024.103886 · Cited by 13
Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders
Weber, T. J., & Quarles, L. D. (2019) · Current Molecular Biology Reports · doi:10.1007/s40610-019-0118-1 · Cited by 15
Ichikawa, S., Gray, A. K., Padgett, L. R., Reilly, A. M., & Unsicker, T. R. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2242 · Cited by 13
Ren, Z., Bütz, D. E., Sand, J. M., & Cook, M. E. (2016) · Poultry Science · doi:10.3382/ps/pew314 · Cited by 13
FGF23 Beyond Mineral Metabolism
Larsson, T. E. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10711011 · Cited by 12
CYP24A1 Regulation in Health and Disease
Petkovich, M. P., Helvig, C. F., & Epps, T. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10080-0 · Cited by 12
Phosphate Dysregulation and Neurocognitive Sequelae
Acquaviva, J., Abdelhady, H. G., & Razzaque, M. S. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-91623-7_13 · Cited by 12
Hypophosphatemia-mediated hypotension in transgenic mice overexpressing human FGF-23
Liu, P., Bai, X., Wang, H., Karaplis, A. C., Goltzman, D., & Miao, D. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00581.2009 · Cited by 12
Self-citationThe parathyroid hormone regulates skin tumour susceptibility in mice
Okumura, K., Saito, M., Yoshizawa, Y., Munakata, H., Isogai, E., Miura, I., Wakana, S., Yamaguchi, M., Shitara, H., Taya, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11561-x · Cited by 12
Self-citationFGF23 as a novel therapeutic target.
Shimada, T., & Fukumoto, S. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-0887-1_10 · Cited by 12
Chen, L., Liu, H., Sun, W. S., Bai, X., Karaplis, A. C., Goltzman, D., & Miao, D. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05526.x · Cited by 12
Self-citationFGF Receptor-Mediated Gene Delivery Using Ligands Coupled to PEI-β-CyD
Hu, Y., Tang, G., Liu, J., Cheng, W., Yue, Y., Li, J., & Zhang, P. (2012) · BioMed Research International · doi:10.1155/2012/989235 · Cited by 11
Self-citationFGF23 and the PTH response to paricalcitol in chronic kidney disease
D’Arrigo, G., Pizzini, P., Cutrupi, S., Tripepi, R., Tripepi, G. L., Mallamaci, F., & Zoccali, C. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13196 · Cited by 11
Cheng, X., Yan, J., Sun, W., Chen, Z. Y., Wu, S., Ren, Z. Z., & Yang, X. (2020) · animal · doi:10.1017/s1751731120001597 · Cited by 11
High Serum Soluble α-Klotho Levels in Patients with Autosomal Dominant Polycystic Kidney Disease
Sarı, F., İnci, A., Dolu, S., Elli̇dağ, H. Y., Çetinkaya, R., & Ersoy, F. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000193 · Cited by 11
High Serum Soluble Cd200 Levels in Patients with Autosomal Dominant Polycystic Kidney Disease
Sarı, F., Gümüşlü, S., Çetinkaya, R., Sarıkaya, M., & Yalçın, A. D. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000326 · Cited by 10
The role of fibroblast growth factor 23 in renal disease
Jonsson, K. B. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh701 · Cited by 10
Ren, Y., Zhao, T., Zhang, K., Zhu, Z., Li, L., Li, Y., Jiang, S., Jiao, N., & Yang, W. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1196334 · Cited by 11
Genetic Disorders of Calcium and Phosphate Homeostasis
Jüppner, H., & Thakker, R. V. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0252-9.50023-9 · Cited by 9
Xu, M., Li, H., Bai, Y., He, J., Chen, R., An, N., Li, Y., & Dong, Y. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.09.013 · Cited by 9
Barratt, K. R., Sawyer, R. K., Atkins, G. J., St‐Arnaud, R., & Anderson, P. (2020) · Bone · doi:10.1016/j.bone.2020.115767 · Cited by 9
Brociek-Piłczyńska, A., Brodowska-Kania, D. A., Szczygielski, K., Lorent, M., Zieliński, G., Kowalewski, P., & Jurkiewicz, D. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00934-7 · Cited by 9
Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway
Hu, P., Huang, B. Y., Xia, X., Xuan, Q., Hu, B., & Qin, Y. H. (2015) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2015.1075041 · Cited by 9
Kusano, K., Saitô, H., Segawa, H., Fukushima, N., & Miyamoto, K. (2009) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.55.99 · Cited by 9
Salim, M., Behairy, M. S., & Barengolts, E. I. (2021) · Case Reports in Endocrinology · doi:10.1155/2021/5172131 · Cited by 8
Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease
Nitta, K. (2010) · International Journal of Nephrology · doi:10.4061/2010/167984 · Cited by 7
Deering, J., Buss, D. J., Kröger, R., Vali, H., Lagos, M. J., Reznikov, N., & McKee, M. D. (2025) · Faraday Discussions · doi:10.1039/d5fd00013k · Cited by 9
High phosphate intake induces bone loss in nephrectomized thalassemic mice
Wanna-udom, S., Luesiripong, C., Sakunrangsit, N., Metheepakornchai, P., Intharamonthian, S., Svasti, S., Greenblatt, M. B., Leelahavanichkul, A., & Lotinun, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268732 · Cited by 7
Liu, D., Yang, F., Zhang, S., Guo, Z., & Peng, S. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12089 · Cited by 6
Liu, Y., Dutra, E. H., Reichenberger, E., & Chen, I. (2016) · Journal of Negative Results in BioMedicine · doi:10.1186/s12952-016-0061-0 · Cited by 6
Phos, phex and FGF: Mysteries of phosphate homeostasis revealed – or still hidden
Strewler, G. J. (2004) · BoneKEy-Osteovision · doi:10.1138/20040134 · Cited by 6
An inducible model for medial calcification based on matrix Gla protein deficiency
Bak, K., Parashar, A., Allgayer, R., Marulanda, J., Gourgas, O., Cerruti, M., & Murshed, M. (2024) · Journal of Structural Biology · doi:10.1016/j.jsb.2024.108144 · Cited by 5
Sitara, D. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.021 · Cited by 5
Fibroblast growth factor-23 may serve as a novel biomarker for renal osteodystrophy progression
Liu, S., Zhang, D., Wu, Y., Luo, H., Jiang, G. M., Xu, Y., Wu, Y., Xia, X., Wei, W., Hu, B., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3934 · Cited by 5
Wyskida, M., Owczarek, A. J., Chełmecka, E., Szczerbowska, I., Mossakowska, M., Grodzicki, T. K., Puzianowska‐Kuźnicka, M., Olszanecka‐Glinianowicz, M., & Chudek, J. T. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110735 · Cited by 5
Physiological and pathophysiological role of endocrine fibroblast growth factors
Łukawska, A., & Mulak, A. (2022) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2022-0045 · Cited by 4
Animal Models of Phosphorus Homeostasis
Beck, L., & Sitara, D. (2019) · Current Molecular Biology Reports · doi:10.1007/s40610-019-0113-6 · Cited by 4
MC8 Peptide-Mediated Her-2 Receptor Targeting Based on PEI-β-CyD as Gene Delivery Vector
Deng, W., Xiao, H., Zeng, X., & Hu, Y. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9959-2 · Cited by 4
Un nouveau système de régulation du bilan du phosphate : Fibroblast Growth Factor 23-Klotho
Prié, D., Ureña, P., & Friedlander, G. (2009) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2009.04.001 · Cited by 4
Hu, L., Andersson, G. N., Jonsson, K. B., Melhus, H., & Lind, T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.056 · Cited by 4
FGF23/Klotho New Regulators of Vitamin D Metabolism
David, V., & Quarles, L. D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10042-3 · Cited by 5
The effects of elevated fibroblast growth factor 23 on mandibular growth in rats
Wu, Y., Zhang, J., & Chen, F. (2018) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2018.07.022 · Cited by 4
Basic molecular mechanism of vascular calcification
Cudrici, C. D., Ferrante, E. A., & Boehm, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816389-4.00003-7 · Cited by 3
Phosphate Homeostasis Regulatory Mechanisms
Bergwitz, C., & Jüppner, H. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-382040-2.10007-3 · Cited by 3
Genetic Defects in Renal Phosphate Handling
Wagner, C. A., Hernando, N., Forster, I. C., Biber, J., & Murer, H. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-449851-8.00043-7 · Cited by 3
Goltzman, D., & Karaplis, A. C. (2015) · Springer eBooks · doi:10.1007/978-88-470-5376-2_8 · Cited by 3
Self-citationEndocrine Regulation of Phosphate Homeostasis
Jüppner, H., & Portale, A. A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373870-7.00009-0 · Cited by 4
Clinical Disturbances of Phosphate Homeostasis
Berndt, T. J., & Kumar, R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00069-0 · Cited by 3
Heritable Renal Phosphate Wasting Disorders
Drezner, M. K., & Whyte, M. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00040-x · Cited by 3
Genetic Disorders of Calcium and Phosphate Homeostasis
Sharma, A., Thakker, R. V., & Jüppner, H. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_11 · Cited by 3
Clinical Disorders of Phosphate Homeostasis
Liu, E. S., & Jüppner, H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00070-5 · Cited by 3
Klotho, an Aging-Suppressor Gene
Rosenblatt, K. P., & Kuro‐o, M. (2007) · Hormone Research in Paediatrics · doi:10.1159/000097581 · Cited by 3
Inghilleri, G., & Franchini, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15124748 · Cited by 2
Impact of Annexin A 7 Deficiency on FGF23 Plasma Concentrations
Umbach, A. T., El-Attar, O., Luo, D., Fakhri, H., Bissinger, R., & Lang, F. J. W. (2016) · Kidney & Blood Pressure Research · doi:10.1159/000452586 · Cited by 2
Silve, C. (2005) · La Presse Médicale · doi:10.1016/s0755-4982(05)84196-x · Cited by 2
Li, S., & Luan, J. (2018) · Aesthetic Plastic Surgery · doi:10.1007/s00266-018-1285-9 · Cited by 2
FGF Signaling in Cartilage Development and Disease
Chen, L., Xie, Y., Xu, M., & Chen, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11186-9 · Cited by 2
Vitamin D and FGF23 in Chronic Kidney Disease
Prié, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-32507-1_10 · Cited by 1
Fernández, E. G., & Luca, B. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70411-0 · Cited by 1
New Insights into the Roles of Fibroblast Growth Factor 23
Yoshiko, Y., Minamizaki, T., & Maeda, N. (2008) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-008-9008-4 · Cited by 1
Goodman, W. G. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00001-x · Cited by 1
The Variety of Osteocyte Function
O’Brien, C. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00006-2 · Cited by 1
Recent Advances in Fibro-blast Growth Factor-23 Functions
Nayani, S. S., & Xiao, Z. (2016) · Nephrology - Open Journal · doi:10.17140/npoj-1-110
Piret, S. E., & Thakker, R. V. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387829-8.00013-5 · Cited by 1
Clinical Disturbances of Phosphate Homeostasis
Berndt, T. J., & Kumar, R. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50073-5 · Cited by 1
Tebben, P. J., Berndt, T. J., & Kumar, R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00016-9 · Cited by 1
Heritable Renal Phosphate Wasting Disorders
Drezner, M. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387829-8.00032-9 · Cited by 1
Bi, J., Bai, R.-J., Zhan, H.-L., Qian, Z., Gong, L. H., Liu, Y., Zheng, Z., & Cai, X. (2022) · Journal of Investigative Medicine · doi:10.1136/jim-2021-002184 · Cited by 1
The renal response to FGF23 shifts from phosphaturia toward inflammation in kidney disease
Moor, M. B., Burmakin, M., Levin, A., Korkut, G. G., Brodin, D., Wernerson, A. M., Bruchfeld, A. N., Barany, P. F., Witasp, A., Patrakka, J., et al. (2026) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70061 · Cited by 1
Regulation of Phosphate Metabolism by FGF23
Lanske, B., Densmore, M., & Razzaque, M. S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-415784-2.00012-9 · Cited by 1
Role of the Kidney in Calcium and Phosphorus Homeostasis
Kumar, J., Woda, C. B., Woroniecki, R. P., Mulroney, S. E., & Kaskel, F. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-3479-7.10130-2 · Cited by 1
Ghonemy, T. A. (2017) · Urology & Nephrology Open Access Journal · doi:10.15406/unoaj.2017.04.00117 · Cited by 1
Chronic Kidney Disease-Mineral Bone Disorder
Moe, S. M., & Sprague, S. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10054-5 · Cited by 1
Endocrine Effects of Space Flight
Hammond, T. G., & Birdsall, H. H. (2022) · Springer eBooks · doi:10.1007/978-3-030-05526-4_6 · Cited by 1
Phosphatonins: new hormones that control phosphorus homeostasis
Marcucci, G., Masi, L., & Brandi, M. L. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.4.513 · Cited by 1
Matrix extracellular phosphoglycoprotein (MEPE): a putative phosphatonin
Dobbie, H. (2011) · UCL Discovery (University College London)
Genetics of Phosphate Regulation Disorders
Gattineni, J. (2013) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0024270
Studies on the phenotype and function of osteoclasts using osteopetrotic and rachitic animal models
Hollberg, K. (2007) · Figshare
25-Hydroxyvitamin D-1α Hydroxylase: Studies in Mouse Models and Implications for Human Disease
Goltzman, D. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9032-z
Self-citationBone Formation and Skeletal Aging - The effects of oxygen tension and DNA repair
Nicolaije, C. (2012) · RePub (Erasmus University Rotterdam)
Fibroblast growth factor 23–Klotho : un nouvel axe de régulation du bilan du phosphate
Prié, D., Torres, P., & Friedlander, G. (2009) · Médecine Nucléaire · doi:10.1016/j.mednuc.2008.10.008
Barros, J. M. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/9s0z-mc96
Хантакова, Е. А., Khamnueva, L. Y., & Орлова, Г. М. (2011) · CyberLeninK (CyberLeninka)
Other Secondary Hyperparathyroid States
Tabatabai, L. S., & de Beur, S. M. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397166-1.00046-1
Potential Role of Vitamin D and Fibroblast Growth Factor 23–Klotho System in Aging
Ahsan, N., Rafi, S. K., Lanske, B., & Razzaque, M. S. (2012) · Oxidative stress and disease · doi:10.1201/b13714-19
Metadata
- Authors
- Bai, X., Miao, D., Li, J., Goltzman, D., & Karaplis, A. C.
- Affiliations
- Jewish General Hospital (CA)
- McGill University Health Centre (CA)
- Corresponding author
- Karaplis, Andrew C.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2004-11-01
- Volume
- 145
- Issue
- 11
- Pages
- 5269-5279
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2144414222
- Cited by
- 329
- References
- 55
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 3 · 2023: 7 · 2022: 9 · 2021: 7 · 2020: 9 · 2019: 11 · 2018: 17 · 2017: 12 · 2016: 25 · 2015: 11 · 2014: 11 · 2013: 13 · 2012: 33
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute
- Canadian Arthritis Network
- Topics
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Health Sciences › Medicine › Nephrology › Renal function and acid-base balance
- Keywords
- fibroblast growth factor 23, parathyroid hormone, renal phosphate wasting, hypophosphatemia, vitamin D metabolism, 1,25-dihydroxyvitamin D3, secondary hyperparathyroidism, calcium homeostasis, osteomalacia, rickets, transgenic mice, furin protease
- MeSH terms
- Fibroblast Growth Factor-23, Animals, Bone and Bones, Calcium, Female, Fibroblast Growth Factors, Carcinoma, Hepatocellular, Humans, Hypophosphatemia, Familial, Kidney Tubules, Proximal, Male, Mice, Transgenic, Osteomalacia, Parathyroid Hormone, Phosphates, Pregnancy, Vitamin D, Gene Expression, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review